Diligent Pharma is a platform that streamlines the selection and qualification of clinical trial service providers.
Diligent Pharma has raised $8.3M in total funding. The most recent round was Series A. The last funding was announced in May 2023.
Diligent Pharma's investors include FCA Venture Partners, PJC, GenHenn Venture.
Diligent Pharma is headquartered in Philadelphia, United States.
Diligent Pharma is a platform that streamlines the selection and qualification of clinical trial service providers.
Diligent Pharma is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Diligent Pharma — Funding & Investors." VCBacked, May 15, 2023, https://www.vcbacked.co/company/diligent-pharma. Accessed September 6, 2026.
VCBacked. (2023). Diligent Pharma — Funding & Investors. Retrieved September 6, 2026, from https://www.vcbacked.co/company/diligent-pharma
{{cite web |title=Diligent Pharma — Funding & Investors |url=https://www.vcbacked.co/company/diligent-pharma |website=VCBacked |access-date=September 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated